Tom 6, Nr 2 (2021)
Artykuł przeglądowy
Opublikowany online: 2021-02-08

dostęp otwarty

Wyświetlenia strony 239
Wyświetlenia/pobrania artykułu 162
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

The role of dermoscopy in dermato-oncological diagnostics – new trends and perspectives

Grażyna Kamińska-Winciorek1, Aleksandra Pilśniak2
Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2021;6(2):124-131.

Streszczenie

Medical history and clinical examination are the most basic elements of medical diagnostics. Clinical examination in the context of dermatology should be combined with the taking and archiving of clinical, dermoscopic and/or video dermoscopic photographs. Dermoscopy is a non-invasive examination and is the recommended method of examining skin lesions. It requires many years of experience and extensive training, and subsequently can be very helpful in the diagnostic process since it allows for a more thorough examination than the unarmed eye. The diagnosis of malignant skin tumours has been significantly improved by noninvasive real-time diagnostic devices. Based on the data from the literature available, we discussed the most commonly used algorithms in the diagnostic process. It should be emphasized that a dermoscopic evaluation may facilitate the diagnosis and early treatment of micromelanoma and basal cell carcinoma. Finally, the role of dermoscopy in the follow-up procedure of oncologic patients should not be forgotten.

Artykuł dostępny w formacie PDF

Pokaż PDF (angielski) Pobierz plik PDF

Referencje

  1. Kamińska-Winciorek G, Gajda M, Wydmański J, et al. What do Web users know about skin self-examination and melanoma symptoms? Asian Pac J Cancer Prev. 2015; 16(7): 3051–3056.
  2. Forsea AM, Tschandl P, Zalaudek I, et al. Eurodermoscopy Working Group. The impact of dermoscopy on melanoma detection in the practice of dermatologists in Europe: results of a pan-European survey. J Eur Acad Dermatol Venereol. 2017; 31(7): 1148–1156.
  3. Rutkowski P, Wysocki PJ, Nasierowska-Guttmejer A, et al. Cutaneous melanoma. Oncol Clin Pract. 2020; 16(4): 163–182.
  4. Bakos RM, Blumetti TP, Roldán-Marín R, et al. Noninvasive Imaging Tools in the Diagnosis and Treatment of Skin Cancers. Am J Clin Dermatol. 2018; 19(Suppl 1): 3–14.
  5. Que SK. Research Techniques Made Simple: Noninvasive Imaging Technologies for the Delineation of Basal Cell Carcinomas. J Invest Dermatol. 2016; 136(4): e33–e38.
  6. Lallas A, Apalla Z, Argenziano G, et al. The dermatoscopic universe of basal cell carcinoma. Dermatol Pract Concept. 2014; 4(3): 11–24.
  7. Russo T, Piccolo V, Lallas A, et al. Dermoscopy of Malignant Skin Tumours: What's New? Dermatology. 2017; 233(1): 64–73.
  8. Kamińska-Winciorek G, Spiewak R. [Basic dermoscopy of melanocytic lesions for beginners]. Postepy Hig Med Dosw (Online). 2011; 65: 501–508.
  9. Soyer HP, Argenziano G, Zalaudek I, et al. Three-point checklist of dermoscopy. A new screening method for early detection of melanoma. Dermatology. 2004; 208(1): 27–31.
  10. Argenziano G, Fabbrocini G, Carli P, et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol. 1998; 134(12): 1563–1570.
  11. Argenziano G, Catricalà C, Ardigo M, et al. Seven-point checklist of dermoscopy revisited. Br J Dermatol. 2011; 164(4): 785–790.
  12. Scope A, Benvenuto-Andrade C, Agero AL, et al. Nonmelanocytic lesions defying the two-step dermoscopy algorithm. Dermatol Surg. 2006; 32(11): 1398–1406.
  13. Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol. 2003; 48(5): 679–693.
  14. Stolz W, Riemann A, Cognetta AB, et al. ABCD rule of dermatoscopy: a new practical method for early recognition of malignant melanoma. Eur J Dermatol. 1994: 4521–4527.
  15. Menzies SW, Ingvar C, Crotty KA, et al. Frequency and morphologic characteristics of invasive melanomas lacking specific surface microscopic features. Arch Dermatol. 1996; 132(10): 1178–1182.
  16. Braun RP, Scope A, Marghoob AA. The "blink sign" in dermoscopy. Arch Dermatol. 2011; 147(4): 520.
  17. Marghoob AA, Braun R. Proposal for a revised 2-step algorithm for the classification of lesions of the skin using dermoscopy. Arch Dermatol. 2010; 146(4): 426–428.
  18. Seiverling EV, Ahrns HT, Greene A, et al. Teaching Benign Skin Lesions as a Strategy to Improve the Triage Amalgamated Dermoscopic Algorithm (TADA). J Am Board Fam Med. 2019; 32(1): 96–102.
  19. Jaimes N, Marghoob AA. Triage amalgamated dermoscopic algorithm. J Am Acad Dermatol. 2020; 82(6): 1551–1552.
  20. Blum A, Argenziano G. Metaphoric and descriptive terminology in dermoscopy: Combine "blink" with "think". Dermatol Pract Concept. 2015; 5(3): 23.
  21. Kittler H, Marghoob AA, Argenziano G, et al. Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy. J Am Acad Dermatol. 2016; 74(6): 1093–1106.
  22. Megaris A, Lallas A, Bagolini LP, et al. Dermoscopy features of melanomas with a diameter up to 5 mm (micromelanomas): A retrospective study. J Am Acad Dermatol. 2020; 83(4): 1160–1161.
  23. Salerni G, Alonso C, Fernández-Bussy R. Multiple Primary Invasive Small-Diameter Melanomas: Importance of Dermoscopy and Digital Follow-up. Dermatol Pract Concept. 2019; 9(1): 69–70.
  24. Salerni G, Alonso C, Fernández-Bussy R. A series of small-diameter melanomas on the legs: dermoscopic clues for early recognition. Dermatol Pract Concept. 2015; 5(4): 31–36.
  25. Babino G, Lallas A, Agozzino M, et al. Melanoma diagnosed on digital dermoscopy monitoring: A side-by-side image comparison is needed to improve early detection. J Am Acad Dermatol. 2020 [Epub ahead of print].
  26. Longo C, Specchio F, Ribero S, et al. Dermoscopy of small-size basal cell carcinoma: a case-control study. J Eur Acad Dermatol Venereol. 2017; 31(6): e273–e274.
  27. Takahashi A, Hara H, Aikawa M, et al. Dermoscopic features of small size pigmented basal cell carcinomas. J Dermatol. 2016; 43(5): 543–546.
  28. Liopyris K, Navarrete-Dechent C, Yélamos O, et al. Clinical, dermoscopic and reflectance confocal microscopy characterization of facial basal cell carcinomas presenting as small white lesions on sun-damaged skin. Br J Dermatol. 2019; 180(1): 229–230.
  29. di Meo N, Damiani G, Vichi S, et al. Interobserver agreement on dermoscopic features of small basal cell carcinoma (<5 mm) among low-experience dermoscopists. J Dermatol. 2016; 43(10): 1214–1216.
  30. Carducci M, Bozzetti M, de Marco G, et al. Preoperative margin detection by digital dermoscopy in the traditional surgical excision of cutaneous squamous cell carcinomas. J Dermatolog Treat. 2013; 24(3): 221–226.
  31. Carducci M, Bozzetti M, De Marco G, et al. Usefulness of margin detection by digital dermoscopy in the traditional surgical excision of basal cell carcinomas of the head and neck including infiltrative/morpheaform type. J Dermatol. 2012; 39(4): 326–330.
  32. Conforti C, Giuffrida R, Zalaudek I, et al. Dermoscopic Findings in the Presurgical Evaluation of Basal Cell Carcinoma. A Prospective Study. Dermatol Surg. 2021; 47(2): e37–e41.
  33. Hamilko de Barros M, Conforti C, Giuffrida R, et al. Clinical usefulness of dermoscopy in the management of lentigo maligna melanoma treated with topical imiquimod: A case report. Dermatol Ther. 2019; 32(5): e13048.
  34. Blum A, Hofmann-Wellenhof R, Marghoob AA, et al. Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society. JAMA Dermatol. 2014; 150(2): 138–145.
  35. Avilés-Izquierdo JA, Ciudad-Blanco C, Sánchez-Herrero A, et al. Dermoscopy of cutaneous melanoma metastases: A color-based pattern classification. J Dermatol. 2019; 46(7): 564–569.
  36. Farnetani F, Manfredini M, Longhitano S, et al. Morphological classification of melanoma metastasis with reflectance confocal microscopy. J Eur Acad Dermatol Venereol. 2019; 33(4): 676–685.
  37. Moscarella E, Rabinovitz H, Puig S, et al. Multiple primary melanomas: do they look the same? Br J Dermatol. 2013; 168(6): 1267–1272.
  38. De Giorgi V, Salvini C, Sestini S, et al. Triple synchronous cutaneous melanoma: a clinical, dermoscopic, and genetic case study. Dermatol Surg. 2007; 33(4): 488–491.
  39. Rutkowski P, Owczarek W, Nejc D, et al. Skin carcinomas. Oncol Clin Pract. 2018; 14(3): 129–147.
  40. Husein-ElAhmed H, Fernandez-Pugnaire MA. Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod. An Bras Dermatol. 2016; 91(6): 764–769.
  41. Diluvio L, Bavetta M, Di Prete M, et al. Dermoscopic monitoring of efficacy of ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas. Dermatol Ther. 2017; 30(1).
  42. Mainetti C, Guillod C, Leoni-Parvex S. Successful Treatment of Relapsing Bowen's Disease with Ingenol Mebutate: The Use of Dermoscopy to Monitor the Therapeutic Response. Dermatology. 2016; 232 Suppl 1: 9–13.
  43. Tognetti L, Cinotti E, Fiorani D, et al. Long-term therapy of multiple basal cell carcinomas: Clinicodermoscopic score for monitoring of intermittent vismodegib treatment. Dermatol Ther. 2019; 32(6): e13097.
  44. Navarrete-Dechent C, Cordova M, Liopyris K, et al. In vivo imaging characterization of basal cell carcinoma cutaneous response to high dose ionizing radiation therapy: A prospective study of reflectance confocal microscopy, dermoscopy, and ultrasound. J Am Acad Dermatol. 2020 [Epub ahead of print].
  45. Richtig E, Arzberger E, Hofmann-Wellenhof R, et al. Assessment of changes in lentigo maligna during radiotherapy by in-vivo reflectance confocal microscopy: a pilot study. Br J Dermatol. 2015; 172(1): 81–87.
  46. Ballester Sánchez R, Pons Llanas O, Pérez Calatayud J, et al. Dermoscopy margin delineation in radiotherapy planning for superficial or nodular basal cell carcinoma. Br J Dermatol. 2015; 172(4): 1162–1163.
  47. Rajczykowski M, Kaminska-Winciorek G, Nowara E, et al. Dermoscopic assessment of skin toxicities in patients with melanoma during treatment with vemurafenib. Postepy Dermatol Alergol. 2018; 35(1): 39–46.
  48. Cohen PR, Bedikian AY, Kim KB. Appearance of New Vemurafenib-associated Melanocytic Nevi on Normal-appearing Skin: Case Series and a Review of Changing or New Pigmented Lesions in Patients with Metastatic Malignant Melanoma After Initiating Treatment with Vemurafenib. J Clin Aesthet Dermatol. 2013; 6(5): 27–37.
  49. https://dermoscopedia.org/.